Haemonetics Corp (HAE) Institutional Ownership

Ownership Summary

Haemonetics Corp (NYSE:HAE) appears in 323 institutional 13F filings for the quarter ending December 2025.

• Collectively, these holders controlled 109.3% of Haemonetics's outstanding shares in December 2025, up from 109.0% in September 2025.
• They increased total shares held in Haemonetics by 5.96% from last quarter, and the number of investors in HAE increased 5.56% annually.
• Among the 323 funds, 166 bought more Haemonetics shares, 130 sold down, and 27 held their ground.
• Institutional investors collectively held 51.37Mn shares in Haemonetics as of December 2025, up by 2.89Mn shares quarter on quarter, and down 7.49Mn shares year over year.
• As of December 31, 2025, the biggest holder of Haemonetics is BlackRock, Inc. at 5.62Mn shares, representing 11.96% of shares outstanding.
• Leading buyers of Haemonetics shares for the quarter ending December 2025 were VANGUARD PORTFOLIO MANAGEMENT LLC (2.56Mn), VANGUARD CAPITAL MANAGEMENT LLC (2.09Mn), Invenomic Capital Management LP (664.73K), PRICE T ROWE ASSOCIATES INC /MD/ (420.28K), VANGUARD FIDUCIARY TRUST CO (323.58K).
• The largest sales of HAE for the quarter ending December 2025 came from Goldman Sachs Group Inc (1.5Mn), Holocene Advisors, LP (1.26Mn), T. Rowe Price Investment Management, Inc. (1.19Mn), CITADEL ADVISORS LLC (1.03Mn), Point72 Asset Management, L.P. (796.51K).
• According to Business Quant data, leading holders of HAE for December 2025 are BlackRock, Inc. (5.62Mn), Neuberger Berman Group LLC (3.56Mn), AQR CAPITAL MANAGEMENT LLC (3.36Mn), VANGUARD PORTFOLIO MANAGEMENT LLC (2.56Mn), VANGUARD CAPITAL MANAGEMENT LLC (2.09Mn), State Street Corp (1.77Mn), ARROWSTREET CAPITAL, LIMITED PARTNERSHIP (1.38Mn), River Road Asset Management, LLC (1.33Mn), DIMENSIONAL FUND ADVISORS LP (1.33Mn), FMR LLC (1.28Mn).